Claudio Montalto (@mdmontalto) 's Twitter Profile
Claudio Montalto

@mdmontalto

MD || interventional cardiologist @ospniguarda || Editor for EHJ-Case Report || SoME @JACCjournals Advances || @MyUnisr Alumni || RT not endorsement

ID: 1167565009989361664

linkhttps://linktr.ee/claudio.montalto calendar_today30-08-2019 22:29:36

253 Tweet

1,1K Followers

922 Following

Nature Cardiovascular Research (@naturecvr) 's Twitter Profile Photo

Review| Banning and colleagues summarize diagnostic techniques, current and emerging interventions for the treatment of #microvascular dysfunction @Memfietzoglou, Giovanni Luigi De Maria Dimitrios Terentes-Printzios Rafail Kotronias MarinF Claudio Montalto nature.com/articles/s4416… 👉rdcu.be/cLzIU

Claudio Montalto (@mdmontalto) 's Twitter Profile Photo

Such a great pleasure to participate di the #stemidtu trial with Ospedale Niguarda This is the first in-person meeting after covid. Looking forward to improve patients care and to contribute to a new paradigm shift in #stemi w/ chief @Abiomed

Such a great pleasure to participate di the #stemidtu trial with <a href="/ospniguarda/">Ospedale Niguarda</a> 
This is the first in-person meeting after covid. Looking forward to improve patients care and to contribute to a new paradigm shift in #stemi 

w/ <a href="/alaide_chief/">chief</a> @Abiomed
Chuck Simonton (@drchucksimonton) 's Twitter Profile Photo

Evolution of STEMI treatment from door-to-balloon to door-to-unload in the STEMI DTU RCT. Tremendous energy at the enrolling sites 24/7 to complete this landmark study, and with unparalleled leadership from the PI’s. Exciting Investigator Summit! William W. O'Neill Navin Kapur

Evolution of STEMI treatment from door-to-balloon to door-to-unload in the STEMI DTU RCT. Tremendous energy at the enrolling sites 24/7 to complete this landmark study, and with unparalleled leadership from the PI’s. Exciting Investigator Summit! <a href="/BillONeillMD/">William W. O'Neill</a> <a href="/NavinKapur4/">Navin Kapur</a>
Frank Harrell (@f2harrell) 's Twitter Profile Photo

#Statistics thought of the day:It is not appropriate to compute a mean or run parametric regression on % change unless you first compute log(% change/100 + 1) to undo damage done by % change fharrell.com/post/percent #statstwitter @vandy_biostat Vanderbilt University Data Science Institute #StatThink #bbrcourse

Felice Gragnano (@felicegragnano) 's Twitter Profile Photo

What is the optimal regimen for #P2Y12 antagonism in #elderly with ACS? A network meta-analysis of RCTs on #ehjcvp provides novel insights 💊⤵️ academic.oup.com/ehjcvp/article… #CardioTwitter #Cardiology Stefan Agewall Claudio Montalto Gabriele Crimi, MD. Italo Porto Azeem Latib antonio mangieri

Felice Gragnano (@felicegragnano) 's Twitter Profile Photo

This is the 1st🥇meta-analysis specifically evaluating the impact of DAPT #duration after PCI in pts with an indication for OAC - irrespective of OAC #type❗ New data in #ehjcvp supports periprocedural #triple therapy💊⤵️ academic.oup.com/ehjcvp/advance… Marco Valgimigli Claudio Montalto Stefan Agewall

This is the 1st🥇meta-analysis specifically evaluating the impact of DAPT #duration after PCI in pts with an indication for OAC - irrespective of OAC #type❗ New data in #ehjcvp supports periprocedural #triple therapy💊⤵️
academic.oup.com/ehjcvp/advance…
<a href="/vlgmrc/">Marco Valgimigli</a> <a href="/MdMontalto/">Claudio Montalto</a> <a href="/AgewallStefan/">Stefan Agewall</a>
Journal Club Channel (@thecardiojc) 's Twitter Profile Photo

📣This week #JournalClub discusses #DAPT duration post #PCI in #HBR & #OAC pat @ESCJournals #EHJ ⭐️Expert Prof. Marco Valgimigli & presenters Claudio Montalto + Francesco Costa 🗓Time: Wed Feb 22nd, 6pm(CET) ➡️DM 4 ZOOM🔗 As a starter s. #BackgroundSession w/🔑literature: linktr.ee/thecardiojc

📣This week #JournalClub discusses #DAPT duration post #PCI in #HBR &amp; #OAC pat @ESCJournals #EHJ

⭐️Expert Prof. <a href="/vlgmrc/">Marco Valgimigli</a> &amp; presenters <a href="/MdMontalto/">Claudio Montalto</a> + <a href="/Costa_F_8/">Francesco Costa</a>

🗓Time: Wed Feb 22nd, 6pm(CET)
➡️DM 4 ZOOM🔗

As a starter s. #BackgroundSession w/🔑literature: linktr.ee/thecardiojc
Journal Club Channel (@thecardiojc) 's Twitter Profile Photo

⭐️Tomorrow at 6️⃣pm CET the #CardioJournalClub is live ➡️Join Prof. Marco Valgimigli & the presenters Claudio Montalto + Francesco Costa who will discuss 2 @ESCJournals papers on #DAPT duration post #PCI in #HBR & #OAC pat 🗓Wed 22nd Feb ⏰6.00 pm (Rome) ➡️DM for ZOOM link🔗

⭐️Tomorrow at 6️⃣pm CET the #CardioJournalClub is live 

➡️Join Prof. <a href="/vlgmrc/">Marco Valgimigli</a> &amp; the presenters <a href="/MdMontalto/">Claudio Montalto</a> + <a href="/Costa_F_8/">Francesco Costa</a> who will discuss 2 @ESCJournals papers on #DAPT duration post #PCI in #HBR &amp; #OAC pat 

🗓Wed 22nd Feb 
⏰6.00 pm (Rome) 
➡️DM for ZOOM link🔗
Francesco Costa (@costa_f_8) 's Twitter Profile Photo

One of the most used definition for Complex PCI in studies and meta-analysis was proposed by Gennaro Giustino, MD chief Antonio Colombo in this paper published on @JACC Demonstrating that Complex PCI benefit from longer DAPT duration jacc.org/doi/abs/10.101…

One of the most used definition for Complex PCI in studies and meta-analysis was proposed by <a href="/g_giustinoMD/">Gennaro Giustino, MD</a> <a href="/alaide_chief/">chief</a> <a href="/Antocol17/">Antonio Colombo</a> in this paper published on @JACC
Demonstrating that Complex PCI benefit from longer DAPT duration

jacc.org/doi/abs/10.101…
EHJ Editor-in-Chief (@ehj_ed) 's Twitter Profile Photo

Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: new meta-analysis in current EHJ issue. #DAPT #platelets #PCI #cardiotwitter European Society of Cardiology Journals European Society of Cardiology

Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: new meta-analysis in current EHJ issue.
#DAPT #platelets #PCI #cardiotwitter <a href="/ESC_Journals/">European Society of Cardiology Journals</a> <a href="/escardio/">European Society of Cardiology</a>
Paolo Crosetto (@paolocrosetto) 's Twitter Profile Photo

Ok this is big. Web of Science just removed the MDPI flagship journal IJERPH from their lists. This means IJERPH has no more an Impact Factor. Why is this big? What are the implications? 🧵

Ok this is big. 

Web of Science just removed the MDPI flagship journal IJERPH from their lists. This means IJERPH has no more an Impact Factor.

Why is this big? What are the implications? 🧵
Pasquale Paolisso (@p_paolisso) 's Twitter Profile Photo

First data of SGLT2i in AS pts - PART 2 🔥In T2DM pts w/ severe AS, LVEF<50%, and cardiac damage undergoing TAVI, the SGLT2i use was associated w/ a more favorable cardiac remodeling and ⬇️risk of MACE A 2-loop-year FU. Read more on 👇#CardiovascularDiabetology cardiab.biomedcentral.com/articles/10.11…

First data of SGLT2i in AS pts - PART 2
🔥In T2DM pts w/ severe AS, LVEF&lt;50%, and cardiac damage undergoing TAVI, the SGLT2i use was associated w/ a more favorable cardiac remodeling and ⬇️risk of MACE <a href="/2/">A 2-loop</a>-year FU.

Read more on 👇#CardiovascularDiabetology
cardiab.biomedcentral.com/articles/10.11…
Alessandro Mandurino Mirizzi (@ale_mm1988) 's Twitter Profile Photo

Our network metanalysis (42 RCTs, 30219 pts) comparing OCT, IVUS, FFR, iFR, angio for guidance to PCI, updated w/ the latest RCTs, on International Journal of Cardiology: 🔸OCT, IVUS, FFR ⬇️cardiac death vs angio 🔸OCT, IVUS ⬇️TLF, TVR, TLR, ST vs angio 🔸OCT ⬇️TLF vs FFR and iFR. sciencedirect.com/science/articl…

Our network metanalysis (42 RCTs, 30219 pts) comparing OCT, IVUS, FFR, iFR, angio for guidance to PCI, updated w/ the latest RCTs, on <a href="/IJCardio/">International Journal of Cardiology</a>:
🔸OCT, IVUS, FFR ⬇️cardiac death vs angio
🔸OCT, IVUS ⬇️TLF, TVR, TLR, ST vs angio
🔸OCT ⬇️TLF vs FFR and iFR. 
sciencedirect.com/science/articl…
Claudio Montalto (@mdmontalto) 's Twitter Profile Photo

🚨 Just published in EuroIntervention! 🫀 Outcomes of complex/high-risk #PCI #CHIP in patients undergoing #TAVI – insights from the #ASCoP registry 📊 Graphical abstract 👇 📖 Read: eurointervention.pcronline.com/article/outcom… #CardioTwitter #StructuralHeart

🚨 Just published in <a href="/EuroInterventio/">EuroIntervention</a>!
🫀 Outcomes of complex/high-risk #PCI #CHIP in patients undergoing #TAVI – insights from the #ASCoP registry

📊 Graphical abstract 👇
📖 Read: eurointervention.pcronline.com/article/outcom…

#CardioTwitter #StructuralHeart